News

Nutrition Zone CEO Pete De Anda said, "I’m delighted to have Vita Cell and Max Plus in our Nutrition Zone stores. I have been on the Vita Cell

TINA molecules placed at the 5′ end of primers, stabilize duplex formation. The intercalators have high sensitivity and specificity of endpoint and PCR. QuantiBact managing director and CEO

KSCP will become a wholly-owned subsidiary of Sagent on the completion of the acquisition. Sagent CEO and chairman Jeffrey Yordon said that its partnership with Kanghong was instrumental

The glatiramer acetate depot formulation is to be injected once-a-month under the skin or into a muscle for a prolonged release of the therapeutic agent. Mapi Pharma president

Alimera Sciences, pSivida’s licensee, has reported the treatment of first patient following the commercial launch in the region. pSivida president and chief executive officer Dr. Paul Ashton said

Sativex is indicated for the treatment of moderate to severe spasticity in multiple sclerosis (MS) in patients who showed inadequate response to other anti-spasticity medications. GW chief executive

Net sales for the first quarter ended 31 March 2013 were Rs6.32bn ($117.13m) compared to Rs6.23bn ($115.46m) for the first quarter ended 31 March 2012. GlaxoSmithKline Pharmaceuticals managing

The company expects to convert manufacturing capacity at the facility to allow future production of the once-weekly GLP-1 analogue type 2 diabetes therapy. Operations at the converted plant

As per the agreement, Astellas’ ASP7035, which completed a phase I study and is yet to enter into phase IIa-study, will be licensed to Tacurion. Tacurion will be